Search results
Individual investors in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) are its biggest bettors, and...
Simply Wall St. via Yahoo Finance· 4 months agoKey Insights Corvus Pharmaceuticals' significant individual investors ownership suggests that the...
Corvus Pharma (CRVS) Stock Surges 69.2% in a Week: Here's Why
Zacks via Yahoo Finance· 12 months agoShares of Corvus Pharma (CRVS) surge 69% this week after the company provided updates on its...
Quite a few insiders invested in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) last year which is...
Simply Wall St. via Yahoo Finance· 1 year agoWhen a single insider purchases stock, it is typically not a major deal. However, when multiple...
We Think Corvus Pharmaceuticals (NASDAQ:CRVS) Needs To Drive Business Growth Carefully
Simply Wall St. via Yahoo Finance· 2 months agoEven when a business is losing money, it's possible for shareholders to make money if they buy a...
Is Corvus Pharmaceuticals (NASDAQ:CRVS) In A Good Position To Deliver On Growth Plans?
Simply Wall St. via Yahoo Finance· 1 year agoJust because a business does not make any money, does not mean that the stock will go down. For...
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 month agoCorvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q4 2023 Earnings Call Transcript March 19, 2024 Corvus...
Corvus (CRVS) Upgraded to Buy: What Does It Mean for the Stock?
Zacks via Yahoo Finance· 1 month agoCorvus Pharmaceuticals (CRVS) appears an attractive pick, as it has been recently upgraded to a...
We're Hopeful That Corvus Pharmaceuticals (NASDAQ:CRVS) Will Use Its Cash Wisely
Simply Wall St. via Yahoo Finance· 2 years agoJust because a business does not make any money, does not mean that the stock will go down. For...
Corvus is using drones to track warehouse inventory
TechCrunch· 2 years agoWay back in August of last year, we highlighted the launch of Corvus Robotics in the Actuator newsletter. The Boston-based firm is one of a handful of...
Corvus' (CRVS) Lymphoma Drug Gets Orphan Status, Stock Up
Zacks via Yahoo Finance· 3 months agoCorvus Pharmaceuticals, Inc. CRVS announced that the FDA granted the Orphan Drug Designation to its...